Research into the aetiological agent of the most widespread form of severe malaria, Plasmodium falciparum, has benefitted enormously from the ability to culture and genetically manipulate blood-stage forms of the parasite in vitro. However, most malaria outside Africa is caused by a distinct Plasmodium species, Plasmodium vivax, and it has become increasingly apparent that zoonotic infection by the closely related simian parasite Plasmodium knowlesi is a frequent cause of life-threatening malaria in regions of southeast Asia. Neither of these important malarial species can be cultured in human cells in vitro, requiring access to primates with the associated ethical and practical constraints. We report the successful adaptation of P. knowlesi to continuous culture in human erythrocytes. Humanadapted P. knowlesi clones maintain their capacity to replicate in monkey erythrocytes and can be genetically modified with unprecedented efficiency, providing an important and unique model for studying conserved aspects of malarial biology as well as speciesspecific features of an emerging pathogen.
Research into the aetiological agent of the most widespread form of severe malaria, Plasmodium falciparum, has benefitted enormously from the ability to culture and genetically manipulate blood-stage forms of the parasite in vitro. However, most malaria outside Africa is caused by a distinct Plasmodium species, Plasmodium vivax, and it has become increasingly apparent that zoonotic infection by the closely related simian parasite Plasmodium knowlesi is a frequent cause of life-threatening malaria in regions of southeast Asia. Neither of these important malarial species can be cultured in human cells in vitro, requiring access to primates with the associated ethical and practical constraints. We report the successful adaptation of P. knowlesi to continuous culture in human erythrocytes. Humanadapted P. knowlesi clones maintain their capacity to replicate in monkey erythrocytes and can be genetically modified with unprecedented efficiency, providing an important and unique model for studying conserved aspects of malarial biology as well as speciesspecific features of an emerging pathogen.
invasion | transfection T he development of a continuous culture system for asexual blood stages of the most deadly human malaria parasite, Plasmodium falciparum (1, 2), proved a milestone in malaria research, enabling genetic modification of the parasite (3), high-throughput drug screening (4) , and other fundamental advances in parasite biology. Adaptation of other human malaria parasite species to in vitro culture has proved more challenging, and none of the additional four parasite species that cause human malaria can be continuously maintained in human RBC. This difficulty is a significant obstacle to studying these pathogens, which differ from P. falciparum in important aspects of biology and the pathology they cause. Furthermore, although considerable progress has been made in the development of transgenic technologies for Plasmodium, P. falciparum remains poorly amenable to genetic manipulation, with a typical transfection efficiency of only ∼10 −6 (5) . Additional in vitro human malaria parasite models that are genetically tractable and that complement the P. falciparum system have tremendous potential.
Much of the early work on the mechanics of RBC invasion by the malaria parasite used the simian parasite Plasmodium knowlesi. This species has a 24-h erythrocytic life cycle and large, long-lived invasive merozoites, facilitating the use of electron and video microscopy to dissect the dynamics of erythrocyte invasion (6) (7) (8) . P. knowlesi can be cultured in vitro in rhesus monkey (Macaca mulata) RBC with rhesus or human serum (9, 10) . Importantly, P. knowlesi is amenable to genetic manipulation, with reported transfection efficiencies similar to those achieved with the rodent malaria model Plasmodium berghei and far surpassing those attained in P. falciparum (10, 11) . P. knowlesi is phylogenetically closely related to Plasmodium vivax, the most important cause of malaria outside of Africa (12) , so its study can provide insights into unique aspects of the biology of P. vivax. P. knowlesi has recently been identified as a significant cause of often severe human malaria in southeast Asia (13, 14) , where it is likely transmitted as a zoonosis from its natural host the kra monkey or cynomolgus macaque (Macaca fascicularis). Collectively, because of the advantages of using P. knowlesi to study the cell biology of the parasite, the recognition of P. knowlesi as an emerging threat, and the recent publication of the P. knowlesi genome (12), P. knowlesi could provide an ideal in vitro malaria parasite model. However, previous attempts to adapt P. knowlesi to culture in human RBC have failed (15) , and the requirement for a supply of macaque RBC and serum has restricted work on this parasite to the very few laboratories worldwide with access to primate facilities.
Here we describe the adaptation of a P. knowlesi line to continuous culture in human RBC without requirement for macaque cells or serum. Importantly, the line retains its capacity to infect macaque cells. Clones derived from the human-adapted P. knowlesi line were used in a scalable 96-well format FACS-based assay to investigate the importance of major human RBC surface polymorphisms for efficient parasite invasion and growth. Using specifically designed P. knowlesi reporter constructs we demonstrate that the humanadapted P. knowlesi clone is highly amenable to genetic manipulation, with a 100,000-fold increased transfection efficiency compared with that achieved for P. falciparum, and exceeding that achieved with P. berghei. This provides an opportunity unique in any malaria parasite species to interrogate the phenotypic consequences of genetic modifications within the first generation of transgenic asexual blood-stage parasites.
Results
Adaptation of P. knowlesi to Long-Term Continuous Culture in Human RBC. We initiated in vitro cultures using frozen stocks from 1976 of the P. knowlesi A1 strain (derived from the P. knowlesi H strain) (16) , which previously had been maintained exclusively in vivo in rhesus macaques. The parasites were added to freshly drawn M. fascicularis RBC at 2% hematocrit in a modified RPMI medium 1640 containing 0.5% (wt/vol) Albumax II and 10% (vol/ vol) human serum in static cultures at 37°C. The medium was changed daily for the first 10 d and every 2-3 d thereafter. In line with the ∼24-h life cycle of P. knowlesi (16) , the parasitaemia initially increased on average twofold daily, but after ∼8 wk in culture this rate had risen steadily to four-to sevenfold per day, with an erythrocytic cycle length of ∼27 h. The resulting cultureadapted line was named A1-O (Fig. 1A) . Attempts to culture the original A1 stock directly in human RBC, or to passage the A1-O parasites into 100% human RBC failed, with very low growth rates and complete loss of parasites within a week. Indirect immunofluorescence analysis (IFA) of the parasites showed that they maintained a strong preference for cynomolgus cells but were capable of invading and developing to schizont stage within human RBC (Fig. 1B) . Accordingly, the A1-O line was divided into two separate cultures, one of which we continued to maintain solely in 100% cynomolgus RBC (called A1-C) (Fig. 1A) ; the second, called A1-H(E), was maintained in a 4:1 mixture of human and cynomolgus cells. We reasoned that this ratio of human to cynomolgus cells would be sufficient to sustain parasite growth in the cynomolgus cells yet confer a selective advantage on those parasites able to invade and replicate within human RBC. After a further 8-mo continuous culture of the A1-H(E) line it was possible to remove cynomolgus cells entirely, with the growth rates in 100% human RBC initially averaging twofold per day, before eventually increasing to three-to fivefold per day. The resulting A1-H line was then cloned by limiting dilution, in parallel with the A1-C line (maintained continuously in cynomolgus cells), producing parasite clones A1-H.1 to A1-H.5, and A1-C.1 to A1-C.2.
Clones A1-H.1 ( Fig. S1 ) and A1-C.1 were selected for detailed characterization. To compare their relative invasion and intracellular growth rates in human and cynomolgus RBC, purified schizonts of each clone were added to fresh macaque or human cells to a parasitaemia of 1%, and then the parasitaemia determined at intervals over the course of the ensuing cycle using a FACS-based protocol. Time points (4 h and 24 h from initiation of the assay) were chosen first to obtain estimates of invasion rate by determining the efficiency of new ring-stage parasite formation following schizont rupture, and second to quantify intracellular growth by determining the parasitaemia as the intracellular parasites reached maturity. The results (Fig. 1C) demonstrated that for the A1-C.1 clone the main barrier to growth in human RBC was low invasion efficiency, although a slight decrease in parasitaemia following invasion may reflect a small defect in intracellular development. In contrast, the A1-H.1 clone could invade and grow in cynomolgus RBC at rates similar to those in human RBC, a remarkable observation given the fact that the A1-H line from which it was derived had been cultured exclusively in human RBC for nearly a year before these assays. (20) , and that this correlates with relatively poor binding of the major P. vivax Duffy-binding protein to the Fy a Duffy isotype. Although we routinely screened the human blood used during culture-adaptation of the P. knowlesi lines for Duffy positivity, we noticed that occasional samples of Duffy-positive blood did not support strong growth of the parasite, raising the possibility that the Duffy phenotype might influence growth rates. The A1-H.1 parasite clone could be readily maintained in 96-well microtiter plates, so we exploited this to examine the Duffy blood-type preference of the clone, as well its dependence on other major blood-type antigens. Purified synchronous A1-H.1 schizonts were added to freshly drawn and washed RBC from 33 volunteers of diverse ethnicity in triplicate (starting parasitaemia ∼1%), and the parasitaemia monitored by FACS over the ensuing two intraerythrocytic cycles (∼48 h). Blood-group phenotyping was performed using an agglutination assay to determine the Duffy, ABO, Kell, and Rhesus D, C, c, E, and e antigens of each blood sample. As shown in Fig. 2A , no significant association between parasite growth rate and the four major blood types was evident. Similar analyses revealed no dependence on Rhesus antigen polymorphisms or the Kell blood type (Fig. S2 ). In contrast, there was a clear dependence on the presence of the Duffy antigen, with no parasite replication in Duffy-negative blood, confirming that a Duffy-dependent invasion pathway is essential for the A1-H.1 clone (Fig. 2B ). In contrast with the indications from the P. vivax study referred to above, no significant differences were observed between growth rates in RBC of the three Duffy-positive phenotypes [ , sustained markedly reduced growth rates (less than sixfold over two cycles). Both of these blood samples produced lower-than-average scores in the agglutination phenotyping assays, suggesting that they were likely heterozygous with a Fy − allele, resulting in reduced Duffy receptor density on the RBC surface (21), and explaining the reduced invasion rate. Ethical restrictions on this study did not permit donor genotyping to confirm this. The P. knowlesi Duffy binding protein-α (DBP-α) plays a key role in invasion of Duffypositive human RBC (22) . Sequencing of the DBP-α gene from the A1-O, A1-H.1, and A1-C.1 parasites and comparison with that of the P. knowlesi H strain (12) identified just a single nonsynonymous polymorphism unique to the A1-H.1 clone (Fig. S3) . Further work will be required to establish whether this plays any role in adaptation to growth in human RBC.
High-Efficiency Transfection with Episomal Constructs Allows Phenotypic
Analysis of First-Generation Transgenic Parasites. Previous work has demonstrated that P. knowlesi cultured in macaque RBC is amenable to genetic manipulation (10) . To explore whether our humanadapted parasites shared similar characteristics, we investigated the efficiency with which the A1-H.1 clone could be transfected with episomal vectors. We initially used vectors based on pHH1 (23) , which is in common use for P. falciparum transgenesis and uses predominantly P. falciparum regulatory sequences to drive transgene and selectable marker expression. Although transfection with these constructs eventually produced drug-resistant parasites, lower than expected transgene expression levels were observed. To improve expression, we replaced the P. falciparum promoters with P. knowlesi sequences, using the Pkef1α 5′ UTR (PlasmoDB ID PKH_111400) to drive the hdhfr selectable marker and the Pkhsp70 5′ UTR (PlasmoDB ID PKH_093190) to drive GFP expression, resulting in plasmid PkconGFP ep (Fig. S4) . Successful transfection in P. berghei relies on the electroporation of purified mature schizonts, so to mimic similar conditions, highly synchronous P. knowlesi A1-H.1 schizonts were produced by centrifugation on Nycodenz cushions. The Amaxa electroporation system has provided significant improvements in transfection efficiency in P. berghei (24) , so PkconGFP ep was introduced into the P. knowlesi schizonts by electroporation with the Amaxa 4D electroporator. Drug selection (2.5 nM WR99210) was applied ∼18 h postelectroporation. To determine transfection efficiencies, parasites transfected in triplicate with either PkconGFP ep or no DNA (mock transfection control) were monitored over the course of 4 d for parasitaemia and proportion of GFP + parasites. As shown in Fig. 3 , ∼30% of the PkconGFP ep -transfected parasites were GFP + on day 1 before the application of drug selection. By day 3 posttransfection, the drug selection had killed almost all of the control parasites, such that by day 4 nearly 100% of the PkconGFP eptransfected parasites were GFP + and at a sufficiently high parasitaemia (∼7%) to enable cryopreservation of the parasites and preparation of material for biochemical analysis. In our hands, attaining these numbers of transgenic P. falciparum parasites with current transfection methodology (using a similar Amaxa electroporation protocol) takes at least 14-21 d, corresponding to an estimated transfection efficiency at least 1,000-fold lower than that reported here with the P. knowlesi A1-H.1 clone.
Rapid Genomic Integration by Homologous Recombination of Linear
DNA Constructs in Human-Adapted P. knowlesi. Disruption, mutagenesis, or tagging of endogenous malarial genes requires integration of DNA constructs into the parasite genome. This integration can currently be achieved with P. falciparum but requires transfection with circular plasmid, which is maintained episomally and can only be removed by either repeated cycles of drug selection or the use of negative selection markers (25) . To determine whether the observed high-transfection efficiency facilitated genomic modification of our human-adapted P. knowlesi parasites, we modified PkconGFP ep to incorporate an ∼1.2-kb region of the Pkp230p gene (PlasmoDB ID PKH_041110), which is dispensable in P. berghei and was therefore considered a suitable targeting sequence for homologous integration (24) . The resulting construct, called PkconGFP p230p , was linearized using a KpnI site situated within the targeting region to prevent its maintenance as a stable episome and to promote integration through single crossover homologous recombination into the P. knowlesi p230p locus (Fig. 4A) . Parasite cultures transfected with PkconGFP p230p contained ∼30% GFP + parasites on day 1, similar to those transfected with PkconGFP ep (Fig. 4B) . Following application of drug selection, however, the proportion of GFP + parasites increased more slowly than observed with the PkconGFP ep construct, but the parasitaemia remained approximately the same for the first 10 d of culture, indicating that the majority of the initial GFP + parasite population contained only the linear, nonintegrated PkconGFP p230p plasmid. Integration into the p230p locus was detectable by PCR as early as day 8 posttransfection, and genotyping of parasites on day 16 demonstrated integration had occurred in a significant proportion of the parasites (Fig. 4C) . Following limiting dilution cloning of the transgenic parasites in the absence of drug, 40% of the resulting clones displayed the expected integration genotype. These clones displayed strong GFP fluorescence throughout the entire erythrocytic lifecycle (Fig. 4D ). Our results demonstrate that genomemodified transgenic P. knowlesi clones can be readily generated without any requirement for drug cycling or negative selection.
Discussion
We have produced a P. knowlesi line and derived clones adapted to robust, continuous growth in human RBC. This process now enables any laboratory with suitable containment facilities to . Black bars indicate mean growth rate in each blood type, and an asterisk denotes Duffy-positive blood groups supporting growth rates significantly different from those in Duffy-negative blood groups (two-tailed t test, P value ≤ 0.001). Growth was highly dependent on Duffy positivity, but showed no dependence on ABO blood type. Note that the four blood samples in A that show low growth rates are the Duffynegative [Fy (a−b−) ] samples.
work on P. knowlesi, with no requirement for macaque blood or serum. Our achievement provides malarial researchers with access to some of the uniquely tractable features of P. knowlesi asexual blood-stage cell biology suitable for studying RBC invasion and the receptor-ligand interactions involved. Analysis of the adaptation process itself should enable us to learn more about determinants of host specificity in malaria. To this end, detailed genome-scale comparisons of the A1-H.1 and A1-C.1 clones are already underway (at both the genomic and RNAseq level) and we anticipate that these will allow identification of the genetic or epigenetic determinants required for growth in human RBC, potentially representing virulence factors important for human P. knowlesi malaria infections. Extended maintenance of Plasmodium in asexual blood-stage form is well documented to result in loss of capacity to form the sexual gametocyte forms essential for mosquito transmission (26) , and indeed none of our culture-adapted lines appears able to produce gametocytes. The genome sequence information may aid in identifying the genetic changes responsible for this, potentially facilitating culture of gametocyte-producing P. knowlesi lines in the future. Using a 96-well microplate-based assay suitable for a medium to high-throughput screen (including drug screens), we were able to demonstrate the requirement for the Duffy antigen in the A1-H.1 clone. Previous single-cycle invasion assays in human RBC using P. knowlesi parasites from infected macaques failed to identify enhanced invasion rates in Fy b+ cells, despite the demonstration that the parasite RBC receptor, DBP, binds more strongly to Fy b+ than Fy a+ RBC (22) . Our experiments, carried out with a fully culture-adapted clone, allowed for improved sensitivity because of higher invasion rates and multiple invasion cycles, but similarly failed to demonstrate any Fy-dependent difference in growth rate. With the caveat that our data arise from the use of a single humanadapted P. knowlesi clone, we suggest that there are fundamental differences between P. vivax and P. knowlesi, or that the recently observed effect of Duffy polymorphisms on the incidence of clinical P. vivax malaria (20) may be because of an increased sensitivity of Fy a+ RBC to invasion-blocking antibodies and in some cases allele dosage, rather than a direct effect on invasion efficiency.
Although the A1-H.1 clone displayed greatly improved invasion and growth rates in human RBC compared with the A1 stock from which it was derived, it maintained the capacity to grow well in macaque RBC, often exhibiting slightly higher replication rates than in human RBC. The fact that this characteristic was retained even after many months of culture exclusively in human RBCs presents the exciting possibility of designing experiments that involve shuttling between both macaque and human host cells in vitro. Previous work has demonstrated that it is possible to establish in vivo infections in rhesus macaques from parasites cultured long-term in rhesus RBCs (10), and we aim to explore whether the A1-H clones (and transgenic mutants thereof) may be suitable for similar experiments. The capacity to combine in vitro experiments with in vivo studies in primate models will be invaluable for investigations of parasite pathogenesis and for vaccine development, particularly vaccines for P. vivax, which shares invasion pathways with P. knowlesi but lacks a long-term in vitro culture system. Extensive in vitro characterization of parasites used for in vivo macaque experiments will improve the value of the in vivo work, an important goal consistent with the replacement, reduction, and refinement principles of ethical animal experimentation.
Using mature schizonts and an Amaxa electroporation system, we have achieved the highest reported transfection efficiency for any malaria parasite. In both P. berghei and P. falciparum, the only parasite species previously used extensively for genetic manipulation, relatively low transfection efficiencies [10 −2 and 10
, respectively (5, 24)] require parasites to undergo several cycles of replication (taking around 1 wk in P. berghei and 14-21 d at best in P. falciparum) before they are at levels sufficient for analysis. One consequence of this delay is that modifications that block parasite invasion or intracellular growth are lethal and the transgenic parasites are never recovered. With our human-adapted P. knowlesi clone we routinely achieve a transfection efficiency of 30-40%, which not only enables more rapid production of transgenic parasites, but also is unique in allowing analysis of transgenic parasites within the first generation following transfection. Thus, parasites expressing episomal transgenes with dominant negative effects could be examined in the first cycle following transfection, using GFP expression to identify the transgenic parasites. Genomic integration of DNA through single or double homologous recombination has been crucial in the delineation of gene function in malaria parasites. We have shown that this result can readily be achieved with our human-adapted clone, using the nonessential p230p gene to target integration into the genome. Recombination efficiencies are highly dependent on the identity and length of the targeting regions used, and increased targeting sequence length has been demonstrated to improve recombination efficiency by up to 10-fold in P. berghei (27) . We therefore anticipate that further increases in integration efficiency are likely with improvements in transfection construct design, such as use of the recently described pJAZZ vector-based recombineering approach to produce linear malarial transfection constructs with long homology arms (27) .
The P. berghei malaria model (24) is the current model of choice for reverse genetic studies. However, in vivo infections with this species are asynchronous, the parasite cannot be cultured in vitro long term, and the strict requirement for mouse work (e.g., for producing parasite clones) are major bottlenecks in moves toward high-throughput production of transgenic parasites. The transfection experiments described here with the P. knowlesi A1-H.1 clone have the potential to be scaled up considerably, because the Amaxa electroporation device settings used are fully compatible with 96-well plates, and we have already demonstrated the parasites can be maintained in this format. This development therefore provides a tantalizing possibility of a genome-wide gene knock-out project in a human malaria pathogen.
Methods
Human and Macaque Blood. Cynomolgus blood was collected by venous puncture into K 2 EDTA vacutainers. Human blood for routine culturing was obtained from the United Kingdom National Blood Transfusion service. Blood for analysis of effect of human blood groups on in vitro growth of P. knowlesi clone A1-H.1 was obtained with full consent from volunteers. Venous blood (∼10 mL) collected into CPDA 1 S-Monovette vials (Sarstedt) was anonymized, and then RBCs washed with RPMI 1640 and stored at 4°C. Blood typing was carried out using DG Gel cards (Grifols) according to the manufacturer's instructions. For ABO, Rhesus, and Kell antigens the DG Gel ABO/CDE and DG Gel Rh + Kell cards were used. For Duffy antigen typing, the DG Gel Coombs card was used along with anti-Fy a and anti-Fy b sera (Lorne Laboratories).
Parasite Adaptation to Growth in Human RBCs. All P. knowlesi parasite cultures were initiated from a 1-mL P. knowlesi A1 stabilate originally frozen in 1976. The sample was thawed and supplemented with 1 mL 0.6 M NaCl added drop-wise before pelleting the cells by centrifugation at 270 × g for 3 min. The supernatant was discarded, a further 1 mL 0. hematocrit and the parasites cultured at 37°C in flasks gassed with a mixture of 90% N 2 , 5% O 2 , and 5% CO 2 . Cultures were monitored by microscopy using Giemsa-stained thin films, and parasitaemia maintained at between 0.5% and 10%. The medium was changed daily for the first 10 d of culture, and every 2-3 d thereafter. For adaptation, A1-C parasites were maintained under the same conditions but in 100% cynomolgus RBC, A1-H(E) parasites were maintained in a mixture of 80% human RBC and 20% macaque RBC, and fully human-adapted parasites (A1-H and derived clones) were maintained in human RBC alone.
Parasite Synchronization. Mature schizonts of culture-adapted P. knowlesi were enriched by centrifugation at 900 × g for 12 min on a cushion of 55% Nycodenz (Axis-Shield) stock solution [27.6% (wt/vol) Nycodenz powder in 10 mM Hepes, pH 7.0], diluted into RPMI medium 1640. The interface containing schizonts was returned to culture with fresh RBCs in complete medium for at least 1 h at 37°C to allow schizont rupture and formation of new ring-stage parasites. The culture was then reapplied to a Nycodenz cushion and centrifuged again, this time discarding the residual schizonts. The pellet, comprising newly invaded ring-stage parasites and uninfected RBCs, was returned to culture. Synchronization was repeated as necessary and always performed in the cycle preceding transfection.
Limiting Dilution Cloning and Cryopreservation of P. knowlesi. Parasite cultures were diluted in complete medium containing RBC (2% hematocrit) to obtain a suspension containing three parasitized cells per milliliter, then 100 μL of this added to each well of a 96-well microtiter plate. Plates were cultured in a gassed chamber, feeding at 3-to 4-d intervals with medium containing RBCs (1% hematocrit) once a week. After ∼2 wk, wells containing growing parasite clones were identified microscopically by Giemsa-stained thin films, then expanded for genotypic and phenotypic analysis. For cryopreservation, 700 μL of freezing solution [111 mM NaCl, 166 mM D-sorbitol, 28% (wt/vol) glycerol] was added drop-wise to 300 μL of pelleted ring-stage parasiteinfected blood before freezing in liquid nitrogen.
Invasion and Growth Assays. A flow cytometry (FACS)-based assay was used to determine parasitaemia in growth and invasion assays. To compare invasion and intraerythrocytic growth rates of the A1-H.1 and A1-C.1 clones, schizonts purified from each line were added in triplicate to either human or macaque blood in 24-well plates (500 μL medium per well 2% hematocrit, and starting schizont parasitaemia ∼1%). Samples of each culture (50 μL) were taken at once and following incubation at 37°C in a gassed chamber for at 5 h or 24 h, for FACS analysis. To measure growth in different human blood samples, a similar assay was used except that triplicate 200-μL cultures were set up for each blood sample, in a 96-well plate; starting parasitaemia was 0.8% and samples (50 μL) were taken at time point 0 and after 48 h for FACS analysis. For FACS analysis, 50 μL of each culture was transferred to wells of a fresh 96-well microtiter plate containing 10 μL hydroethidine solution (50 μg/mL). The plate was incubated at 37°C for 20 min, then samples fixed by addition of 10 μL of 0.04% (wt/vol) glutaraldehyde with incubation for 1 h at 4°C. Samples were analyzed within 24 h of fixation on a FACScalibur (BD). For this process, the sample from each well was diluted into 500 μL PBS, transferred to a FACS tube, and analyzed using CellQuest software (BD) for acquisition and analysis, as described previously (28) .
DNA Constructs and PCR. DNA constructs for use in P. knowlesi transfection experiments were adapted from pHH4, a derivative of plasmid pHH1 (23) . To produce vector PkconGFP ep , the PfCAM promoter was removed by digestion with BglII and BamHI and replaced with ∼600 bp of sequence from directly upstream of the Pkef1α gene (PlasmoDB ID PKH_111400), amplified by PCR using oligonucleotide primers ol097 and ol098 (Table S1 ). To drive a GFP reporter gene, an ∼1,300-bp fragment upstream of the Pkhsp70 gene (PlasmoDB ID PKH_093190) was amplified by PCR with ol103 and ol104 and cloned into the construct using the NotI and XmaI sites. Finally the eGFP ORF was amplified with primers ol111 and ol112 and cloned between the Pkhsp70 promoter region and the PbDT 3′ UTR already present in the construct using the XmaI and SacII restriction sites. To create plasmid PkconGFP p230p , 1,281 bp of the p230p locus was amplified using primers ol107 and ol108. The fragment was cloned into PkconGFP ep linearized with EcoRI using an In-Fusion HD cloning kit (Clontech). PkconGFP p230p was linearized for transfection using the KpnI site situated within the p230p fragment.
Transfection of P. knowlesi. Tightly synchronized mature schizonts were purified by centrifugation over a Nycodenz cushion. Transfections were carried out using the Amaxa 4D electroporator (Lonza) and the P3 Primary cell 4D Nucleofector X Kit L (Lonza). For each transfection, DNA (20 μg) was dissolved in 10 μL TE (10 mM Tris•HCl, 1 mM EDTA, pH 8.0), then 100 μL of supplemented P3 primary cell solution added. Approximately 5-10 μL of schizonts (∼5 × 10 7 -10 8 ) were resuspended in the DNA plus P3 primary cell solution and immediately electroporated in a 4D Nucleofector X Kit L cuvette (Lonza) using program FP158. Electroporated parasites were transferred to a 1.4-mL Eppendorf tube containing 500 μL prewarmed complete medium plus 150 μL fresh RBC, and incubated at 37°C on a thermomixer, shaking at 650 rpm while further transfections were carried out. After 30-40 min, transfected parasites were transferred to wells of a six-well plate, each containing 4.5 mL warm complete medium. Plates were cultured at 37°C in a gassed chamber. After 24 h, and subsequently at daily intervals, the medium was replaced with fresh medium containing 2.5 nM WR99210.
Transgenic P. knowlesi Genotyping and Phenotype Analysis. Parasites transfected with plasmid PkconGFP p230p were genotyped by diagnostic PCR using parasite DNA purified by DNeasy blood and tissue kit (Qiagen) according to the manufacturer's protocol. For diagnostic PCR, three different primer sets were used. The first primer pair (ol145and ol146) was designed to amplify a 1,320-bp fragment only from an intact wild-type p230p locus. The second primer pair (ol145 and ol144) was designed to only amplify a 1,455-bp fragment after correct integration of PKconGFP p230p into the p230p locus. The third primer pair (ol75and ol76) is a positive control designed to amplify a 1,043-bp region of the Pkmtip gene in all parasites. PCR reactions (3 min at 96°C, then 35 cycles of 25 s at 96°C, 25 s at 52°C, and 2 min at 64°C, and a final extension of 5 min at 64°C) were carried out using GoTaq Mastermix (Promega) with 1-μL DNA template in a 25-μL reaction with 300 nM each primer.
Microscopy. Macaque and human RBC were distinguished by IFA as described previously (29) using a rabbit antiserum raised by immunization with human RBC ghost preparations (diluted 1:5,000), which detects both macaque and human cells, and mouse monoclonal anti-Band 3 antibody clone BIII-136 (Sigma; diluted 1:5,000), which detects only human cells. Antibody binding was detected with anti-mouse IgG Alexafluor-594 (Invitrogen) diluted 1:5,000, and an anti-rabbit IgG Alexafluor-488 (Invitrogen) diluted 1:5,000. Slides were stained with DAPI (0.5 μg/mL) and mounted in Vectashield (Vector Laboratories).
To determine proportions of GFP + cells, parasite cultures were labeled with Hoechst 33342 (Invitrogen) (1 μg/mL). Parasitized cells were identified using brightfield and nuclear staining, then scored visually for GFP expression. For live imaging of the PkconGFP p230p integrant P. knowlesi clone, Hoechst 33342-stained schizonts in complete medium were mixed with one volume of Matrigel (BD) on ice. The mixture was placed on a microscope slide, overlaid with a Vaseline-rimmed coverslip and allowed to set at room temperature. Samples were imaged on an Axioimager M1 microscope (Zeiss) with an Axiocam MRm camera and using Axiovision (Zeiss) acquisition software. Z-stack images were taken with a 250-nm step size and deconvoluted using Volocity 5. 
